Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial
article
OA: closed
CC0
⤵ 62 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This randomized trial compared the efficacy of a levonorgestrel-releasing intrauterine system to a low-dose combined oral contraceptive for treating adenomyotic uteri.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis via openalex
- Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis via openalex
- Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging via openalex
- [Effect of levonorgestrel-releasing intrauterine system combined with GnRH analogue for treatment of large adenomyosis]. via openalex
- [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis]. via openalex
- Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis via openalex
- Levonorgestrel-Releasing Intrauterine System vs. Usual Medical Treatment for Menorrhagia: An Economic Evaluation Alongside a Randomised Controlled Trial via openalex
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
- Ultrasound diagnosis of adenomyosis, leiomyoma, or combined with histopathological correlation via openalex
- Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy via openalex
- Understanding clinical features of adenomyosis: a case control study. via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of adenomyosis associated heavy menstrual bleeding. via openalex
- W6706560450 via openalex
- W6841831896 via openalex
- W6842111680 via openalex
- W2007561870 via openalex
- W2042677510 via openalex
- W2090979444 via openalex
- W2100147679 via openalex
- W2119515611 via openalex
- W2131027406 via openalex
- W2165185898 via openalex
- W6608847589 via openalex
- W6610896475 via openalex
- W6651920706 via openalex
- W6675454867 via openalex
Cited by (50)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Histopathological insights into treatment failure with the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding: a retrospective study 2026
- Updates on adenomyosis and fertility 2025
- Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society 2025
- The present adenomyosis treatment status in Luzhou, China: a small scope observational cross-sectional survey 2025
- Different prophylactic measures for preventing postoperative deep venous thromboembolism in adenomyosis: a retrospective study 2025
- Adenomyosis: Unravelling the causes and exploring treatment strategies among patients seeking conception 2025
- Comparison of safety and efficacy of hysteroscopic LNG-IUS fixation surgery and conventional LNG-IUS placement in the treatment of adenomyosis: A retrospective cohort study 2025
- Factors associated with dysmenorrhoea and menorrhagia improvement in patients with adenomyosis after uterine artery embolisation 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping 2024
- Consider fertility-preserving medications when treating adenomyosis 2024
- Contraception et adénomyose 2024
- Non-surgical Treatment of Adenomyosis 2024
- The Role of Different Medical Therapies in the Management of Adenomyosis: A Systematic Review and Meta-Analysis 2024
- Efficacy of etonogestrel subcutaneous implants versus the levonorgestrel-releasing intrauterine system in the conservative treatment of adenomyosis 2024
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Evaluation of Endpoints Used in Clinical Trials on Adenomyosis - A Systematic Review 2023
- [Directive clinique no 437 : Diagnostic et prise en charge de l'adénomyose] 2023
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Guideline No. 437: Diagnosis and Management of Adenomyosis 2023
- Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer 2023
- Current diagnosis and management of adenomyosis in Canada: A survey of Canadian gynaecologists 2022
- Medical Treatment of Adenomyosis 2022
- Long-term Efficacy and Safety of Levonorgestrel - releasing Intrauterine System in the Treatment of Adenomyosis: Evidence Mapping and Meta-analysis 2022
- Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer 2022
- Levonorgestrel-releasing intrauterine system vs. systemic medication or blank control for women with dysmenorrhea: Systematic review and meta-analysis of randomized controlled trials 2022
- Progesterone Actions and Resistance in Gynecological Disorders 2022
- Prise en charge des ménorragies : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF) 2022
- An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis 2022
- Diagnosis and Surgical Management of Adenomyosis 2022
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- Nonsurgical management of adenomyosis: an overview of current evidence 2022
- Uterine Artery Embolization for Symptomatic Adenomyosis: Proceedings from a Society of Interventional Radiology Foundation Research Consensus Panel 2022
- Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review 2022
- Adenomyosis and Abnormal Uterine Bleeding 2021
- Characterization of patients that can continue conservative treatment for adenomyosis 2021
- Levonorgestrel Releasing Intrauterine System for the Treatment of Endometriosis: A Meta-Analysis 2021
- Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial 2021
- Current and Prospective Treatment of Adenomyosis 2021
- Characterization of patients that can continue conservative treatment for adenomyosis 2021
- Current and Future Medical Therapies for Adenomyosis 2020
- IMMUNOLOGICAL FACTORS IN THE DIAGNOSIS OF THE SEVERITY OF THE CLINICAL COURSE OF ADENOMYOSIS 2020
- Adenomiosis. Una gran desconocida: ¿Qué debemos saber? 2020
- Adenomyosis and Infertility 2019
- [Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis]. 2019
- Treatment of symptomatic adenomyosis with the levonorgestrel‐releasing intrauterine system 2019
- CONTROVERSIAL ISSUES OF RADIOLOGIC DIAGNOSIS OF ADENOMYOSIS IN REPRODUCTIVE LOSSES 2019
Source provenance
- europepmc
- last seen: 2026-06-19T06:14:56.452680+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:52.213533+00:00
License: CC0
· commercial use OK